Article Processing Charges
Journal of Rare Cardiovascular Diseases does not collect any article processing charges from author(s) or authors’ sponsors for any type of article. This means that publication process including peer-reviewing, editing, publishing, maintaining and archiving is conducted free of charge for author(s) or authors’ sponsors. Open access format of the Journal allows the scientific community and the general public to have, for free, unlimited and immediate access to all content of the journal as soon as it is published on the Internet.
Publication Ethics
All research must have been carried out within an appropriate ethical framework.
Plagiarism, duplicate submission, data fabrication or falsification are serious acts of misconduct. When scientific misconduct is alleged, or concerns are otherwise raised about the conduct or integrity of work described in submitted or published papers, appropriate procedures detailed by the Committee on Publication Ethics (COPE) will be initiated.
Material (such as illustrations) taken from other publications must be accompanied by the publisher’s permission with a notice ‘Reproduced with permission of …’.
Statement on Human Rights
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to the Editor on request.
Statement of Informed Consent
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript.
Statement of Informed Consent for publication of individual patient data
For all manuscripts that include details, images, videos or other identifying characteristics relating to individual participants, written informed consent for the publication of these should be obtained from the participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. In cases where images or other materials containing participant’s characteristics are entirely unidentifiable and there are no details on individuals reported within the manuscript, consent for publication of these materials may not be required. The final decision on whether consent to publish is required lies with the Editor.
Statement on Animal Rights
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the Directive 2010/63/EU) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption).
Authorship
We advise to follow the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals in identifying authors of the manuscript. To qualify as an author one should have (all 4 required):
1. made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
2. been involved in drafting the manuscript or revising it critically for important intellectual content;
3. given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content;
4. agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section.
Standards of Reporting
Journal of Rare Cardiovascular Diseases advocates complete and transparent reporting of biomedical and biological research. Authors are recommended to adhere to the EQUATOR Network when preparing their manuscript
Availability of data and materials
Submission of a manuscript to the Journal of the Rare Cardiovascular Diseases implies that materials described in the manuscript, including all relevant raw data, will be freely available to any scientist wishing to use them for non-commercial purposes, without breaching participant confidentiality.
Corrections and retractions
If correction or retraction of article(s) published in this Journal are necessary, the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and the Committee on Publication Ethics (COPE) guidelines will be implemented.
